Is systemic prednisone (prednisone) safe for use during pregnancy, and what are the recommended dose limits and potential fetal risks?

Can Pregnant Women Take Prednisone?

Yes, pregnant women can take prednisone when medically necessary, but it should be used at the lowest effective dose, ideally tapered to ≤5 mg/day when possible, with careful monitoring for dose-related maternal and fetal complications. 1, 2

Safety Profile and Risk Assessment

Prednisone and prednisolone are considered low-risk corticosteroids during pregnancy because only 10% of the maternal concentration crosses the placenta to reach fetal blood. 3 The FDA classifies prednisone as Pregnancy Category C, meaning animal studies show adverse effects but there is no evidence that prednisone or methylprednisolone are teratogenic in humans at therapeutic doses. 4, 5

Key Evidence on Fetal Risks

The evidence on birth defects is conflicting but generally reassuring:

• A large nationwide cohort study of nearly 52,000 pregnancies with first-trimester corticosteroid exposure showed no increased risk of orofacial clefts. 1
• However, some older studies reported a 3-fold increased risk of isolated cleft lip ± cleft palate with first-trimester use, though the absolute risk remains low. 3
• The major benefit of systemic corticosteroids in severe disease exceeds the possible fetal risk. 3

Dose-Related Complications

Higher doses and prolonged use carry increased risks:

• Daily doses ≤5 mg are associated with low risk for both mother and fetus. 2
• Higher doses (>5 mg/day) over prolonged periods may increase risk of:
  • Preterm birth 3, 6
  • Low birth weight 3
  • Pre-eclampsia 3
  • Gestational diabetes 2
  • Pregnancy-associated osteoporosis 2
  • Premature rupture of membranes 7, 8

Research demonstrates dose-dependent effects: Women with rheumatoid arthritis receiving high cumulative prednisone doses early in pregnancy had a 4.77-fold increased risk of preterm birth compared to no corticosteroid use, while medium doses showed a 1.81-fold increase. 6 Daily doses ≥10 mg after gestational day 139 were associated with a 2.45-fold increased preterm birth rate. 6

Clinical Management Recommendations

Dosing Strategy

The guideline-recommended approach is:

• Continue regular low-dose prednisone (≤5 mg/day) when needed for disease control. 2, 9
• Taper high-dose prednisone when possible with addition of pregnancy-compatible disease-modifying drugs if needed. 2, 9
• Use the lowest effective dose necessary to maintain disease control. 1, 3
• The benefits of controlling severe maternal disease outweigh potential fetal risks. 3

Neonatal Monitoring

If high-dose prednisone continues until delivery:

• Infants should be carefully observed for signs of adrenal insufficiency. 3, 5
• Substitution with hydrocortisone may be necessary when parenteral administration is needed. 3

Breastfeeding Considerations

Prednisone is compatible with breastfeeding:

• Corticosteroids are excreted minimally into breast milk. 4
• For doses <20 mg daily, breastfeeding is safe without restrictions. 9
• For doses ≥20 mg daily, delay breastfeeding for 3-4 hours after the dose to minimize infant exposure. 3, 9

Common Pitfalls to Avoid

1. Don't abruptly discontinue prednisone in pregnant women with active disease—uncontrolled maternal illness poses greater risk than continued low-dose therapy. 3

2. Don't confuse prednisone/prednisolone with dexamethasone or betamethasone—the latter cross the placenta readily and are used specifically for fetal indications, not maternal disease control. 4

3. Don't forget perioperative stress-dose coverage—pregnant women on chronic corticosteroids need adequate glucocorticoid replacement for cesarean delivery (though not for vaginal delivery). 9

4. Don't overlook maternal monitoring—pregnant women on corticosteroids require surveillance for gestational diabetes, hypertension, and infection risk. 2